ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Kenacort-A 40 200 mg/5 mL, Injektionssuspension - Durchstechflasche(n) à 5 ml
32990045 Dermapharm AG
Kenacort-A 40 200 mg/5 mL, Injektionssuspension12.07.1967
  02.04.2015
Triamcinolone (H02AB08)06.09.2005
WHO-DDD 
07.07.24.Durchstechflasche(n) à 5 ml
07.07.24. 
B  
No 
IP 
PR  
k.A.PR
  
7680329900453Synthetika
  
Composition
triamcinoloni acetonidum 200 mg, alcohol benzylicus 49.5 mg, carmellosum natricum, polysorbatum 80, natrii chloridum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad suspensionem pro 5 ml corresp. natrium 16.5 mg.
Packungsbestandteile
Injection suspension
 
 
Active AgentDose
Triamcinolone Acetonide200mg / 5ml
 
Inactive agentsDose
Acidum Hydrochloridum ad Ph 
Alcohol Benzylicus49.5mg / 5ml
Carmellose Sodium 
Sodium Chloride 
Natrii Hydroxidum ad Ph 
Polysorbatum 80 
Source
Data was imported : 03.02.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home